Association between delayed initiation of adjuvant CMF or anthracycline-based chemotherapy and survival in breast cancer: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Association between delayed initiation of adjuvant CMF or anthracycline-based chemotherapy and survival in breast cancer: a systematic review and meta-analysis

Published:2013-05-16 Issue:1 Volume:13 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Yu Ke-Da,Huang Sheng,Zhang Jia-Xin,Liu Guang-Yu,Shao Zhi-Ming

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1471-2407-13-240.pdf

Reference36 articles.

1. Peto R, Davies C, Godwin J, Gray R, Pan HC, Clarke M, Cutter D, Darby S, McGale P, Taylor C: Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet. 2012, 379 (9814): 432-444.

2. Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thurlimann B, Senn HJ: Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol. 2011, 22 (8): 1736-1747. 10.1093/annonc/mdr304.

3. Fedewa SA, Ward EM, Stewart AK, Edge SB: Delays in adjuvant chemotherapy treatment among patients with breast cancer are more likely in African American and Hispanic populations: a national cohort study 2004–2006. J Clin Oncol. 2010, 28 (27): 4135-4141. 10.1200/JCO.2009.27.2427.

4. Samur M, Bozcuk HS, Dalmaz G, Karaveli S, Köseoğlu FG, Colak T, Pestereli E: Treatment delay in breast cancer; does it really have an impact on prognosis?. Turk J Canc. 2002, 32 (4): 138-147.

5. Kerbrat P, Roche H, Fumoleau P, Bonneterre J, Romestaing P, Fargeot P, Namer M, Monnier A, Montcuquet P, Goudier M: Does time interval between surgery and adjuvant chemotherapy initiation modify treatment efficacy in operable, breast cancer patients? French Adjuvant Study Group (FASG) Results. J Clin Oncol. 2005, 23 (16S): 660-

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review on the effect of immediate autologous microsurgical breast reconstruction on the timely initiation of adjuvant therapy;Plastic and Aesthetic Research;2024-06-28

2. Fusobacterium nucleatum-mimicking nanovehicles to overcome chemoresistance for breast cancer treatment by eliminating tumor-colonizing bacteria;Chem;2024-06

3. Association Between Copayment Assistance, Insurance Type, Prior Authorization, and Time to Receipt of Oral Anticancer Drugs;JCO Oncology Practice;2024-01

4. Association between delayed initiation of treatment indications and survival in patients with cervical cancer: a systematic review and meta-analysis;European Journal of Gynaecological Oncology;2024

5. Breast cancer and public healthcare: survey and proposals from Brazilian Society of Mastology (SBM);Mastology;2024